Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Theek

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
BMC Gastroenterology|October 3, 2013
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trialHubert Mönnikes, Thomas Schwan, Christo van Rensburg, et al.
Cardiology|October 5, 2006
Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionDan Atar, Kurt Huber, Hans-Jürgen Rupprecht, et al.
European Heart Journal|November 27, 2020
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled studyJörg Täubel, Wilfried Hauke, Steffen Rump, et al.
Plos One|February 11, 2016
Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer PatientsBettina Schlick, Petra Massoner, Angelika Lueking, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
BMC Gastroenterology|October 3, 2013
Possible etiology of improvements in both quality of life and overlapping gastroesophageal reflux disease by proton pump inhibitor treatment in a prospective randomized controlled trialHubert Mönnikes, Thomas Schwan, Christo van Rensburg, et al.
Cardiology|October 5, 2006
Rationale and design of the 'F.I.R.E.' study. A multicenter, double-blind, randomized, placebo-controlled study to measure the effect of FX06 (a fibrin-derived peptide Bbeta(15-42)) on ischemia-reperfusion injury in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionDan Atar, Kurt Huber, Hans-Jürgen Rupprecht, et al.
European Heart Journal|November 27, 2020
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled studyJörg Täubel, Wilfried Hauke, Steffen Rump, et al.
Plos One|February 11, 2016
Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer PatientsBettina Schlick, Petra Massoner, Angelika Lueking, et al.
Pageof 2